New

YD Pharmaceuticals

The AI engine Fit Assessment

Beta

The company demonstrates Pharma tech alignment by operating a GMP-certified indoor facility for medical cannabis, producing pharmaceuticals (including generics and APIs) and pursuing research and development, which aligns with central Pharma tech criteria.

Blurb

YD Pharmaceuticals provides pharmaceutical products, including generic drugs, active pharmaceutical ingredients, and healthcare solutions.

HQ Location

Porto (Portugal)

Founded

2022

Employees

11 - 50

Total funding raised

$9.26M

Funding Status

Series A, $9.26M, May 4, 2024

YD Pharmaceuticals is a pharmaceutical company, with an EU-GMP certified indoor facility producing medical cannabis and distributing to EU Countries and other markets.



With a 5,000m2 state of the art indoor facility located near Porto, YD Pharmaceuticals is strategically positioned to meet patient needs across all markets.



Quality, stability, transparency and patient focus are YD Pharmaceuticals core values.